Gabelli Funds reviews Q2 2025 market volatility, tariff impact, and fund positioning. Discover how global trends shaped ...

See why Cytokinetics, Incorporated's aficamten could become the first-line therapy for obstructive HCM, surpassing metoprolol and Camzyos. Click for my CYTK update.

The big slide. This has realtors giddy. Lenders have their fingers hovering above the ‘CUT!’ button. Politicians watching the ...